BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27499035)

  • 1. An 'Omics' Perspective on Cardiomyopathies and Heart Failure.
    Raghow R
    Trends Mol Med; 2016 Sep; 22(9):813-827. PubMed ID: 27499035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
    Lu D; Wang J; Li J; Guan F; Zhang X; Dong W; Liu N; Gao S; Zhang L
    Cardiovasc Res; 2018 Feb; 114(2):300-311. PubMed ID: 29155983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
    Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of molecular mechanisms in myocardial hypertrophy, particular morphological changes and cell bioenergetic characteristics in patients with dilated cardiomyopathy.
    Branishte T; Minciuna V; Braniste A
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):851-6. PubMed ID: 24502060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial cardiomyopathy with different clinical features in individual members].
    Kudo K; Yamada M; Imai H; Katagiri M; Ozawa S; Ida Y; Okada R
    J Cardiol; 1987 Dec; 17(4):907-14. PubMed ID: 3506615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human heart failure: dilated versus familial hypertrophic cardiomyopathy.
    Alpert NR; Warshaw DM
    Adv Exp Med Biol; 2003; 538():77-87; discussion 87-8. PubMed ID: 15098656
    [No Abstract]   [Full Text] [Related]  

  • 10. Collective transcriptomic deregulation of hypertrophic and dilated cardiomyopathy - Importance of fibrotic mechanism in heart failure.
    Malgija B; Kumar NS; Piramanayagam S
    Comput Biol Chem; 2018 Apr; 73():85-94. PubMed ID: 29471264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathies: An Overview.
    Ciarambino T; Menna G; Sansone G; Giordano M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
    Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
    Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
    Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
    Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms in cardiomyopathy.
    Dadson K; Hauck L; Billia F
    Clin Sci (Lond); 2017 Jul; 131(13):1375-1392. PubMed ID: 28645928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of dilated cardiomyopathy (DCM) from idiopathic hypertrophic cardiomyopathy (IHCM) vs. inflammatory dilated cardiomyopathy (DCMi): a rare case of sudden death in an 8-year-old boy.
    Dettmeyer R; Schmidt P; Kandolf R; Madea B
    Pathol Res Pract; 2004; 200(5):411-5; discussion 417-21. PubMed ID: 15239350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.
    Hwang JJ; Allen PD; Tseng GC; Lam CW; Fananapazir L; Dzau VJ; Liew CC
    Physiol Genomics; 2002 Jul; 10(1):31-44. PubMed ID: 12118103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?
    Willott RH; Gomes AV; Chang AN; Parvatiyar MS; Pinto JR; Potter JD
    J Mol Cell Cardiol; 2010 May; 48(5):882-92. PubMed ID: 19914256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomeres and Cardiac Growth: Tension in the Relationship.
    Haldar SM; Srivastava D
    Trends Mol Med; 2016 Jul; 22(7):530-533. PubMed ID: 27237981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.